HLB SCIENCE Company Description

HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases.

Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases.

The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023.

The company was founded in 2016 and is based in Seoul, South Korea.

HLB SCIENCE Inc.

Country	South Korea
Founded	2016
Industry	Biological Products, Except Diagnostic Substances
CEO	Yoon Jongsun

Contact Details

Address: 66, Achasan-ro Seoul, 04782 South Korea
Phone	82 2 6925 0379
Website	hlbscience.com

Stock Details

Ticker Symbol	343090
Exchange	Korea New Exchange
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Yoon Jongsun	Chief Executive Officer